Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) EBT Margin (2025)

Centessa Pharmaceuticals has reported EBT Margin over the past 1 years, most recently at 164.92% for Q1 2025.

  • Quarterly EBT Margin changed N/A to 164.92% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 1304.75% through Dec 2025, changed N/A year-over-year, with the annual reading at 1304.75% for FY2025, N/A changed from the prior year.
  • EBT Margin was 164.92% for Q1 2025 at Centessa Pharmaceuticals.
  • Over five years, EBT Margin peaked at 164.92% in Q1 2025 and troughed at 164.92% in Q1 2025.